[Undesirable metabolic effects following the administration of higher doses of fructose and sorbitol].
D000244:Adenosine Diphosphate / Q000378:metabolism; D000249:Adenosine Monophosphate / Q000378:metabolism; D000255:Adenosine Triphosphate / Q000378:metabolism; D000818:Animals; D056486:Chemical and Drug Induced Liver Injury / Q000209:etiology; D004305:Dose-Response Relationship, Drug; D005632:Fructose / Q000008:administration & dosage / Q000009:adverse effects*; D005947:Glucose / Q000008:administration & dosage; D006505:Hepatitis / Q000628:therapy; D006801:Humans; D008099:Liver / Q000187:drug effects / Q000378:metabolism* / Q000648:ultrastructure; D010288:Parenteral Nutrition / Q000009:adverse effects; D051381:Rats; D013012:Sorbitol / Q000008:administration & dosage / Q000009:adverse effects*; D014527:Uric Acid / Q000097:blood
D014527:Uric Acid; D005632:Fructose; D000249:Adenosine Monophosphate; D013012:Sorbitol; D000244:Adenosine Diphosphate; D000255:Adenosine Triphosphate; D005947:Glucose
Unerwünschte Stoffwechselwirkungen bei Gabe höherer Dosen von Fruktose und Sorbit